Callitas Health Inc. Aktie Deutsche Boerse AG
Aktien
A2GSU1
CA13125C1068
T3F3
Biotechnologie
Umsatz 2018 | 0.75 0.7 0.68 | Umsatz 2019 | 0.71 0.66 0.64 | Marktwert | 3.53 Mio. 3.28 Mio. 3.19 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -4.65 Mio. -4.52 Mio. | Nettoergebnis 2019 | -1 Mio. -929’515 -903’800 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 296’506 288’303 | Nettoschuld 2019 | 847’693 787’943 766’145 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
+17.72% | 44.87 Mrd. | |
-10.33% | 37.8 Mrd. | |
+40.54% | 37.61 Mrd. | |
+29.36% | 31.32 Mrd. | |
-8.44% | 27.4 Mrd. | |
+12.45% | 26.32 Mrd. | |
+44.19% | 14.07 Mrd. | |
+31.93% | 12.5 Mrd. | |
-7.67% | 11.23 Mrd. |